Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Isabel Ferreiro Neira"'
Autor:
James C. Cusack, Theodore S. Hong, Sharon Shacham, William Senapedis, Yosef Landesman, Tristan Penson, Carlos H.F. Chan, Lukas F. Liesenfeld, Nancy E. Torres, Isabel Ferreiro-Neira
Supplementary Figure 1. Selinexor induces HT29 and LoVo cell apoptosis; Supplementary Figure 2. Combination of radiation and Selinexor reduces tumor cell radiation survival; Supplementary Figure 3. Body weight of female nude mice; Supplementary Figur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34826d9ec48cf25f481783de3f51c2fa
https://doi.org/10.1158/1078-0432.22458240.v1
https://doi.org/10.1158/1078-0432.22458240.v1
Autor:
James C. Cusack, Theodore S. Hong, Sharon Shacham, William Senapedis, Yosef Landesman, Tristan Penson, Carlos H.F. Chan, Lukas F. Liesenfeld, Nancy E. Torres, Isabel Ferreiro-Neira
Purpose: Combination of radiation with radiosensitizing chemotherapeutic agents improves outcomes for locally advanced rectal cancer. Current treatment includes 5-fluorouracil–based chemoradiation prior to surgical resection; however pathologic com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5af96ea866428cc190e43b8371befde2
https://doi.org/10.1158/1078-0432.c.6523884.v1
https://doi.org/10.1158/1078-0432.c.6523884.v1
Autor:
Dennie T Frederick, Roberto A Salas Fragomeni, Aislyn Schalck, Isabel Ferreiro-Neira, Taylor Hoff, Zachary A Cooper, Rizwan Haq, David J Panka, Lawrence N Kwong, Michael A Davies, James C Cusack, Keith T Flaherty, David E Fisher, James W Mier, Jennifer A Wargo, Ryan J Sullivan
Publikováno v:
PLoS ONE, Vol 9, Iss 7, p e101286 (2014)
While response rates to BRAF inhibitiors (BRAFi) are high, disease progression emerges quickly. One strategy to delay the onset of resistance is to target anti-apoptotic proteins such as BCL-2, known to be associated with a poor prognosis. We analyze
Externí odkaz:
https://doaj.org/article/8814805ec5d04e5395a5f296e5e3124d
Autor:
Karidia Konate, Marion Dussot, Eric Vivès, Isabel Ferreiro Neira, Franck Couillaud, Anaïs Vaissière, Sébastien Deshayes, Gudrun Aldrian, Véronique Viguier, Prisca Boisguerin
Publikováno v:
Bioconjugate Chemistry
Bioconjugate Chemistry, American Chemical Society, 2019, 30 (3), pp.592-603. ⟨10.1021/acs.bioconjchem.8b00776⟩
Bioconjugate Chemistry, American Chemical Society, 2019, 30 (3), pp.592-603. ⟨10.1021/acs.bioconjchem.8b00776⟩
Delivery of small interfering RNA (siRNA) as a therapeutic tool is limited due to critical obstacles such as the cellular barrier, the negative charges of the siRNA molecule, and its instability in serum. Several siRNA delivery systems have been cons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f856dfcda0fd21b0b3a04a090d19c86
https://hal.archives-ouvertes.fr/hal-02197245
https://hal.archives-ouvertes.fr/hal-02197245
Autor:
William Senapedis, Sharon Shacham, Carlos H. F. Chan, Nancy E. Torres, James C. Cusack, Tristan Penson, Lukas F. Liesenfeld, Theodore S. Hong, Isabel Ferreiro-Neira, Yosef Landesman
Publikováno v:
Clinical Cancer Research. 22:1663-1673
Purpose: Combination of radiation with radiosensitizing chemotherapeutic agents improves outcomes for locally advanced rectal cancer. Current treatment includes 5-fluorouracil–based chemoradiation prior to surgical resection; however pathologic com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c4da26558c1823937fd6915516bfda4
https://doi.org/10.1158/1078-0432.ccr-15-0978
https://doi.org/10.1158/1078-0432.ccr-15-0978
Autor:
Fugen Li, Li-Lun Ho, Isabel Ferreiro-Neira, Kodandaramireddy Nalapareddy, Annouck Luyten, Ramesh A. Shivdasani, Tae-Hee Kim, Michael P. Verzi, Henry W. Long
Publikováno v:
Nature
A study investigating the mechanisms underlying lateral inhibition and lineage plasticity in the mouse small intestine crypts in vivo finds that crypt cells maintain a permissive chromatin state upon which a transcription factor acts to determine lin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7574c5981fada0fa1e140af8e3b6acf0
http://europepmc.org/articles/PMC4151315
http://europepmc.org/articles/PMC4151315
Autor:
Zachary A. Cooper, Aislyn Schalck, Isabel Ferreiro-Neira, James C. Cusack, Ryan J. Sullivan, Marc R. Hammond, Keith T. Flaherty, Jennifer A. Wargo, Dennie T. Frederick, D. P. Lawrence
Publikováno v:
European Journal of Cancer. 50:102
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e94e42bf552627ac6fe71c09cec9197c
https://doi.org/10.1016/s0959-8049(14)70440-x
https://doi.org/10.1016/s0959-8049(14)70440-x
Autor:
Lawrence N. Kwong, Keith T. Flaherty, Rizwan Haq, James C. Cusack, Jennifer A. Wargo, Ryan J. Sullivan, David E. Fisher, Roberto A. Salas Fragomeni, Isabel Ferreiro-Neira, Zachary A. Cooper, Aislyn Schalck, Dennie T. Frederick, James W. Mier, Taylor Hoff, Michael A. Davies, David J. Panka
Publikováno v:
PLoS ONE
PLoS ONE, Vol 9, Iss 7, p e101286 (2014)
PLoS ONE, Vol 9, Iss 7, p e101286 (2014)
While response rates to BRAF inhibitiors (BRAFi) are high, disease progression emerges quickly. One strategy to delay the onset of resistance is to target anti-apoptotic proteins such as BCL-2, known to be associated with a poor prognosis. We analyze
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb784a6eafd7d25e720cfa807d511c84
https://doi.org/10.1371/journal.pone.0101286
https://doi.org/10.1371/journal.pone.0101286